利用丹麦人群的尸检组织研究 CYP2C9、CYP2C19、CYP2D6 和 CYP3A5 基因型与肝脏蛋白质表达之间的相关性。

IF 4.4 3区 医学 Q1 PHARMACOLOGY & PHARMACY
Kata W Pedersen, Jeppe D Andersen, Jakob Hansen, Claus Børsting, Jytte Banner, Jørgen B Hasselstrøm, Jakob R Jornil
{"title":"利用丹麦人群的尸检组织研究 CYP2C9、CYP2C19、CYP2D6 和 CYP3A5 基因型与肝脏蛋白质表达之间的相关性。","authors":"Kata W Pedersen, Jeppe D Andersen, Jakob Hansen, Claus Børsting, Jytte Banner, Jørgen B Hasselstrøm, Jakob R Jornil","doi":"10.1124/dmd.124.001692","DOIUrl":null,"url":null,"abstract":"<p><p>The cytochrome P450 (CYP) family of enzymes plays a central role in the metabolism of many drugs. CYP genes are highly polymorphic, which is known to affect protein levels, but for some low frequent CYP genotypes the correlation between genotype and CYP protein expression is less established. In this study, we determined the <i>CYP2C9, CYP2C19, CYP2D6,</i> and <i>CYP3A5</i> genotypes of 250 Danish individuals included in a postmortem study. For 116 of the individuals, the hepatic CYP protein levels were investigated by a proteomics approach. Overall, we found the postmortem genetic and proteomic data to be in agreement with those of other studies performed on fresh hepatic tissue, showing the usability of postmortem hepatic tissue for this type of investigation. For less investigated genotypes, we could corroborate previously found results: 1) statistically significantly lower levels of hepatic CYP2C9 protein in individuals carrying the <i>CYP2C9</i>*3 variant compared with individuals with two wild type (wt) alleles; 2) comparable levels of CYP2C19 in <i>CYP2C19*2/*17</i> and <i>CYP2C19*1/*2</i> individuals; 3) reduced CYP2D6 protein levels in heterozygous individuals with the <i>CYP2D6*3</i>, <i>CYP2D6</i>*4, and <i>CYP2D6</i>*5 gene deletion variants; and 4) significantly lower levels of CYP3A5 protein in <i>CYP3A5</i>*3 homozygous individuals compared with individuals who were heterozygous for the <i>CYP3A5</i>*3 allele or homozygous individuals for the wt alleles. In conclusion, the use of postmortem tissue significantly increases the access to human specimens for research purposes, and postmortem proteomics can be used to investigate the link between <i>CYP</i> genotypes and hepatic protein expression. SIGNIFICANCE STATEMENT: In tissue samples from a large postmortem cohort (<i>n</i> = 250) we determined the <i>CYP2C9</i>, <i>CYP2C19</i>, <i>CYP2D6</i>, and <i>CYP3A5</i> genotypes. Hepatic CYP protein levels were investigated in 116 individuals using a proteomics approach. For common genotypes, we found results similar to previous knowledge, pointing toward the usability of postmortem tissue. For the less investigated genotypes, we were able to corroborate genotype/protein expression correlations. It is a novel approach to use a large postmortem cohort to investigate genetic/protein expression correlations.</p>","PeriodicalId":11309,"journal":{"name":"Drug Metabolism and Disposition","volume":" ","pages":"975-980"},"PeriodicalIF":4.4000,"publicationDate":"2024-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Investigating the Correlation between Genotypes and Hepatic Protein Expression of <i>CYP2C9, CYP2C19, CYP2D6,</i> and <i>CYP3A5</i> Using Postmortem Tissue from a Danish Population.\",\"authors\":\"Kata W Pedersen, Jeppe D Andersen, Jakob Hansen, Claus Børsting, Jytte Banner, Jørgen B Hasselstrøm, Jakob R Jornil\",\"doi\":\"10.1124/dmd.124.001692\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The cytochrome P450 (CYP) family of enzymes plays a central role in the metabolism of many drugs. CYP genes are highly polymorphic, which is known to affect protein levels, but for some low frequent CYP genotypes the correlation between genotype and CYP protein expression is less established. In this study, we determined the <i>CYP2C9, CYP2C19, CYP2D6,</i> and <i>CYP3A5</i> genotypes of 250 Danish individuals included in a postmortem study. For 116 of the individuals, the hepatic CYP protein levels were investigated by a proteomics approach. Overall, we found the postmortem genetic and proteomic data to be in agreement with those of other studies performed on fresh hepatic tissue, showing the usability of postmortem hepatic tissue for this type of investigation. For less investigated genotypes, we could corroborate previously found results: 1) statistically significantly lower levels of hepatic CYP2C9 protein in individuals carrying the <i>CYP2C9</i>*3 variant compared with individuals with two wild type (wt) alleles; 2) comparable levels of CYP2C19 in <i>CYP2C19*2/*17</i> and <i>CYP2C19*1/*2</i> individuals; 3) reduced CYP2D6 protein levels in heterozygous individuals with the <i>CYP2D6*3</i>, <i>CYP2D6</i>*4, and <i>CYP2D6</i>*5 gene deletion variants; and 4) significantly lower levels of CYP3A5 protein in <i>CYP3A5</i>*3 homozygous individuals compared with individuals who were heterozygous for the <i>CYP3A5</i>*3 allele or homozygous individuals for the wt alleles. In conclusion, the use of postmortem tissue significantly increases the access to human specimens for research purposes, and postmortem proteomics can be used to investigate the link between <i>CYP</i> genotypes and hepatic protein expression. SIGNIFICANCE STATEMENT: In tissue samples from a large postmortem cohort (<i>n</i> = 250) we determined the <i>CYP2C9</i>, <i>CYP2C19</i>, <i>CYP2D6</i>, and <i>CYP3A5</i> genotypes. Hepatic CYP protein levels were investigated in 116 individuals using a proteomics approach. For common genotypes, we found results similar to previous knowledge, pointing toward the usability of postmortem tissue. For the less investigated genotypes, we were able to corroborate genotype/protein expression correlations. It is a novel approach to use a large postmortem cohort to investigate genetic/protein expression correlations.</p>\",\"PeriodicalId\":11309,\"journal\":{\"name\":\"Drug Metabolism and Disposition\",\"volume\":\" \",\"pages\":\"975-980\"},\"PeriodicalIF\":4.4000,\"publicationDate\":\"2024-08-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Drug Metabolism and Disposition\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1124/dmd.124.001692\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Metabolism and Disposition","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1124/dmd.124.001692","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

细胞色素(CYP)P450 家族酶在许多药物的代谢过程中发挥着核心作用。众所周知,CYP 基因具有高度多态性,会影响蛋白质水平,但对于一些低频 CYP 基因型,基因型与 CYP 蛋白表达之间的相关性还不太确定。在这项研究中,我们测定了一项尸检研究中 250 名丹麦人的 CYP2C9、CYP2C19、CYP2D6 和 CYP3A5 基因型。对其中 116 人的肝脏 CYP 蛋白水平进行了蛋白质组学研究。总体而言,我们发现死后基因和蛋白质组学数据与其他在新鲜肝组织上进行的研究数据一致,这表明死后肝组织可用于此类调查。对于研究较少的基因型,我们可以证实之前发现的结果:1)与具有两个野生型(wt)等位基因的个体相比,携带 CYP2C9*3 变体的个体肝脏 CYP2C9 蛋白水平在统计学上明显较低;2)CYP2C19*2/*17 和 CYP2C19*1/*2 个体的 CYP2C19 水平相当、3)CYP2D6*3、CYP2D6*4 和 CYP2D6*5 基因缺失变异杂合子个体的 CYP2D6 蛋白水平降低;以及 4)与 CYP3A5*3 等位基因杂合子个体或 wt 等位基因同源个体相比,CYP3A5*3 同源个体的 CYP3A5 蛋白水平显著降低。总之,死后组织的使用大大增加了用于研究目的的人体标本的获取途径,死后蛋白质组学可用于研究 CYP 基因型与肝脏蛋白质表达之间的联系。意义声明 在一个大型尸检队列(n=250)的组织中,我们确定了 CYP2C9、CYP2C19、CYP2D6 和 CYP3A5 的基因型。我们采用蛋白质组学方法调查了 116 人的肝脏 CYP 蛋白水平。对于常见的基因型,我们发现结果与之前的知识相似,这表明死后组织是可用的。对于调查较少的基因型,我们能够证实基因型与蛋白质表达的相关性。利用大型尸检队列研究基因/蛋白质表达相关性是一种新方法。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Investigating the Correlation between Genotypes and Hepatic Protein Expression of CYP2C9, CYP2C19, CYP2D6, and CYP3A5 Using Postmortem Tissue from a Danish Population.

The cytochrome P450 (CYP) family of enzymes plays a central role in the metabolism of many drugs. CYP genes are highly polymorphic, which is known to affect protein levels, but for some low frequent CYP genotypes the correlation between genotype and CYP protein expression is less established. In this study, we determined the CYP2C9, CYP2C19, CYP2D6, and CYP3A5 genotypes of 250 Danish individuals included in a postmortem study. For 116 of the individuals, the hepatic CYP protein levels were investigated by a proteomics approach. Overall, we found the postmortem genetic and proteomic data to be in agreement with those of other studies performed on fresh hepatic tissue, showing the usability of postmortem hepatic tissue for this type of investigation. For less investigated genotypes, we could corroborate previously found results: 1) statistically significantly lower levels of hepatic CYP2C9 protein in individuals carrying the CYP2C9*3 variant compared with individuals with two wild type (wt) alleles; 2) comparable levels of CYP2C19 in CYP2C19*2/*17 and CYP2C19*1/*2 individuals; 3) reduced CYP2D6 protein levels in heterozygous individuals with the CYP2D6*3, CYP2D6*4, and CYP2D6*5 gene deletion variants; and 4) significantly lower levels of CYP3A5 protein in CYP3A5*3 homozygous individuals compared with individuals who were heterozygous for the CYP3A5*3 allele or homozygous individuals for the wt alleles. In conclusion, the use of postmortem tissue significantly increases the access to human specimens for research purposes, and postmortem proteomics can be used to investigate the link between CYP genotypes and hepatic protein expression. SIGNIFICANCE STATEMENT: In tissue samples from a large postmortem cohort (n = 250) we determined the CYP2C9, CYP2C19, CYP2D6, and CYP3A5 genotypes. Hepatic CYP protein levels were investigated in 116 individuals using a proteomics approach. For common genotypes, we found results similar to previous knowledge, pointing toward the usability of postmortem tissue. For the less investigated genotypes, we were able to corroborate genotype/protein expression correlations. It is a novel approach to use a large postmortem cohort to investigate genetic/protein expression correlations.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
6.50
自引率
12.80%
发文量
128
审稿时长
3 months
期刊介绍: An important reference for all pharmacology and toxicology departments, DMD is also a valuable resource for medicinal chemists involved in drug design and biochemists with an interest in drug metabolism, expression of drug metabolizing enzymes, and regulation of drug metabolizing enzyme gene expression. Articles provide experimental results from in vitro and in vivo systems that bring you significant and original information on metabolism and disposition of endogenous and exogenous compounds, including pharmacologic agents and environmental chemicals.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信